Neurology, ophthalmology, orl

Aus coViki

(Unterschied zwischen Versionen)

Wechseln zu: Navigation, Suche

Aktuelle Version vom 12. September 2020, 17:22 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

 D further streaming-in related content is here

Eye - Conjunctivitis
Eye - Reviews and Multitopic

ORL - any

32415003 2020. Do SARS-CoV2 viral proteins have neuromodulatory properties?
32490972 2020. COVID-19 and the eye: how much do we really know? A best evidence review.
32443834 2020. Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients.

32348111 ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?

32322822 ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC
32328364 ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy
32370982 ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review
32363146 2020. COVID-19 Presenting with Seizures
32307298 ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis
32232433 2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China
32344366 2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report
32478706 2020. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?
32374367 ä. Delirium: a missing piece in the COVID-19 pandemic puzzle
32333819 2020. COVID-19: what if the brain had a role in causing the deaths?

32301553 2020. Lack of dyspnea in patients with Covid-19: another neurological conundrum?

32246784 ä. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID?19

32246782 2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2
32291797 2020. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration

32388138 2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection

32342265 ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome
32457227 2020. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.
32390132 2020. Trombosis venosa cerebral e infeccion por SARS-CoV-2.
32482781 2020. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.
32461235 2020. Guillain-Barre syndrome related to SARS-CoV-2 infection.
32444427 2020. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?
32386285 2020. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.
32352450 2020. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.
32463395 2020. The involvement of the central nervous system in patients with COVID-19.
32355007 2020. The mystery of the pandemic's 'happy hypoxia'.
32286214 2020. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].
32400371 2020. [Anosmia and ageusia as primary symptoms of COVID-19].
32476394 2020. Otorinolaringologicheskie aspekty techeniya zabolevaniya u detei, infitsirovannykh virusom SARS-CoV-2.
32468632 2020. Olfactory dysfunction in recovered COVID-19 patients.
32512352 2020. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.
32442268 2020. Stroke in a young COVID -19 patient.
32484418 2020. Focal Cerebral Arteriopathy in a COVID-19 Pediatric Patient.
32437314 2020. COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages.
32437313 2020. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: An Italian Multicenter Retrospective Observational Study.
32407258 2020. COVID-19-Associated Leukoencephalopathy.
32510821 2020. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor.
32506730 2020. Oral Manifestations in Coronavirus Disease 2019 (COVID-19).
32506662 2020. Necrotizing periodontal disease: oral manifestation of COVID-19.
32419568 2020. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.
32453685 2020. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.
32490966 2020. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.
32469246 2020. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.
32436441 2020. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.
32423359 2020. Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.
32423285 2020. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses.
32502296 2020. SARS-CoV2 as a potential trigger of neurodegenerative diseases.
32502289 2020. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead.
32348051 2020. Anosmie et COVID-19.
32501861 2020. Considering the potential for an increase in chronic pain following the COVID-19 pandemic.
32404789 2020. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms.
32468450 2020. New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases.
32444493 2020. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.
32444492 2020. Bilateral transient olfactory bulbs edema during COVID-19-related anosmia.
32439822 2020. Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection.
32439821 2020. Generalized myoclonus in COVID-19.
32487714 2020. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.
32482845 2020. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.
32424429 2020. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.
32496534 2020. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients.
32490520 2020. Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients.

32392566 2020. The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack.

32487282 2020. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.
32445201 2020. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia.
32505222 2020. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.
32503883 2020. Defining causality in COVID-19 and neurological disorders.
32507577 2020. COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.
32458578 2020. COVID-19 encephalopathy masquerading as substance withdrawal.
32453517 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.
32453516 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.
32453515 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.
32497292 2020. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection.
32432682 2020. Olfactory Dysfunction in COVID-19: Diagnosis and Management.
32469387 2020. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.
32497288 2020. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.
32504746 2020. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.
32427357 2020. Encephalopathy in patients with COVID-19: 'Causality or coincidence?'
32418237 2020. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".
32484990 2020. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.
32451359 2020. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.
32492193 2020. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).
32504100 2020. Ocular manifestations of coronavirus disease 2019.
32437033 2020. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.
32437022 2020. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.
32507468 2020. Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment.
32461325 2020. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.
32406374 2020. Olfactory dysfunction in the COVID-19 outbreak.
32505878 2020. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.
32412510 2020. Neurological manifestations of COVID-19.
32398625 2020. Coincidence of COVID-19 Infection and Smell: Taste Perception Disorders.
32505431 2020. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.
32505432 2020. Does COVID-19 cause axonal GBS?
32436835 2020. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.
32408926 2020. Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?
32501751 2020. EXPRESS: Brain ischemic and hemorrhagic complications of COVID-19.
32497397 2020. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients?
32496658 2020. Reply to: Psychophysical olfactory testing in COVID-19: Is smell function really impaired in nearly all patients?
32503820 2020. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.
32441248 2020. The impact of SARS-CoV-2 on sleep.
32507123 2020. Self-reported anosmia and dysgeusia as key symptoms of COVID-19.
32478675 2020. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19).
32460415 2020. Dysphagia in COVID-19 -multilevel damage to the swallowing network?
32433817 2020. Prolonged Confusional state as first manifestation of COVID-19.
32503088 2020. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.
32503084 2020. Miller-Fisher syndrome after SARS-CoV-2 infection.
32503080 2020. Concomitant brain arterial and venous thrombosis in a COVID-19 patient.
32492256 2020. How to support the quality of life of people living with cognitive disorders? A (k)new challenge in the post-Covid World.
32478936 2020. SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with favorable outcome.
32450718 2020. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?
32443166 2020. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).
32449247 2020. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study.
32416028 2020. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.
32468862 2020. L..: malignant MCA infarct in a patient with COVID 19 infection.
32463454 2020. Alterations in smell or taste - Classic COVID-19?
32436625 2020. Low risk of SARS-CoV-2 transmission through the ocular surface.
32484130 2020. COVID-19 associated central nervous system vasculopathy.
32474587 2020. COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.
32491829 2020. SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis.
32421258 2020. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.
32403983 2020. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children.
32468972 2020. Guillain-Barre syndrome with facial diplegia related to SARS-CoV-2 infection.
32493536 2020. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy.
32473022 2020. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.
32420954 2020. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.
32413158 2020. Headaches During COVID-19: My Clinical Case and Review of the Literature.
32470238 2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection.
32451564 2020. Temporare Hyposmie bei COVID-19-Patienten.
32426230 2020. Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient.
32467191 2020. Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States.
32467190 2020. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.
32467189 2020. Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.
32439646 2020. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.
32409316 2020. Cerebrovascular Disease in COVID-19.
32354715 2020. Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.
32483943 2020. Episcleritis as an ocular manifestation in a patient with COVID-19.
32514394 2020. Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19).
32519260 2020. Thalassemic Child Presenting with Anosmia due to COVID-19.
32461419 2020. Commentary: Exploring the transmission of COVID-19 through the ocular surface.
32461418 2020. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients.
32410112 2020. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients.
32532937 2020. Neurologic aspects of covid-19: a concise review.
32425285 2020. Retrospective Analysis of Smell and Taste Disturbances Associated with Dermatological Medications Reported to the United States Food and Drug Administration and Relevance to COVID-19 Infections.
32535294 2020. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.
32363809 2020. Smell and taste symptom-based predictive model for COVID-19 diagnosis.
32410386 2020. Smell and taste alterations in Covid-19: a cross-sectional analysis of different cohorts.
32395917 2020. Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor?
32395913 2020. Reply to: Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor?
32271490 2020. A primer on viral-associated olfactory loss in the era of COVID-19.
32279441 2020. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.
32526392 2020. Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?
32531341 2020. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report.
32410788 2020. Facial diplegia, a possible atypical variant of Guillain-Barre Syndrome as a rare neurological complication of SARS-CoV-2.
32456959 2020. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.
32453100 2020. Novel Coronavirus (COVID-19)-Associated Guillain-Barre Syndrome: Case Report.
32519322 2020. Self-Reported Loss of Smell and Taste in SARS-CoV-2 Patients: Primary Care Data to Guide Future Early Detection Strategies.
32425479 2020. MRI evaluation of the olfactory clefts in patients with SARS-CoV-2 infection revealed an unexpected mechanism for olfactory function loss.

32427468 2020. Autonomic Brain Centers and Pathophysiology of COVID-19.

32524537 2020. A complication of coronavirus disease 2019: delirium.
32430637 2020. COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report.
32412088 2020. Neurological Manifestations of COVID-19: A systematic review and current update.
32466862 2020. Alteraciones del olfato en la COVID-19, revision de la evidencia e implicaciones en el manejo de la pandemia.
32527987 2020. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients.
32519994 2020. Vertigo and hearing loss during the COVID-19 pandemic - is there an association?
32414522 2020. Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19).
32506549 2020. COVID-19: A Global Threat to the Nervous System.
32425470 2020. Altered Mental Status as a Novel Initial Clinical Presentation for COVID-19 Infection in the Elderly.
32527141 2020. Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study.
32473756 2020. Neuroleptic malignant syndrome in patients with COVID-19.
32425321 2020. Neurologic complications of COVID-19.
32530597 2020. Happy Hypoxemia in COVID-19-A Neural Hypothesis.
32531619 2020. Olfactory and gustatory dysfunctions in COVID-19. First reports of Latin-American ethnic patients.
32527845 2020. Evolving Neuroimaging Findings during COVID-19.
32527844 2020. Neurovascular Complications in COVID-19 Infection: Case Series.
32527843 2020. Neuroimaging Findings in Patients with COVID-19.
32527842 2020. Neurologic Involvement in COVID-19: Cause or Coincidence? A Neuroimaging Perspective.
32388880 2020. Guillain-Barre syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
32395550 2020. 2019 novel coronavirus pneumonia with onset of dizziness: a case report.
32418288 2020. Steroid-Responsive Encephalitis in Coronavirus Disease 2019.
32395831 2020. Rapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19.
32419756 2020. Alteration of Consciousness as Initial Presentation in COVID-19: Observation.
32419755 2020. COVID-19 and Epilepsy.
32419754 2020. COVID-19 and Underlying Cerebrovascular Disease: Analysis on Association.
32419753 2020. COVID 19: Neuromuscular Manifestations.
32419751 2020. 2019-NCoV: What Every Neurologist Should Know?
32407609 2020. De Novo Status Epilepticus in patients with COVID-19.
32410763 2020. Acute olfactory loss is specific for Covid-19 at the Emergency Department.
32516656 2020. Clinical characteristics associated with persistent olfactory and taste alterations in COVID-19: A preliminary report on 121 patients.
32336572 2020. New type of corona virus induced acute otitis media in adult.
32307189 2020. Audiological profile of asymptomatic Covid-19 PCR-positive cases.
32526530 2020. COVID-19 sampling from the middle ear and mastoid: A case report.
32386897 2020. Comment on "Hearing loss and COVID-19: A note".
32471704 2020. Central Nervous System Involvement in COVID-19.
32517875 2020. Epidemia COVID-19: inverted question markdebe el oftalmologo estar alerta ante las paresias oculomotoras?
32404376 2020. Hypogeusia as the initial presenting symptom of COVID-19.
32449883 2020. Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19.
32533727 2020. Report of EEG Finding on Critically Ill Patients with COVID-19.
32468830 2020. Taste and Smell Dysfunction in COVID-19 Patients.
32530389 2020. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease (COVID-19).
32479992 2020. Identifying causal role of COVID-19 in immunopsychiatry models.
32497777 2020. The neuroinvasive potential of severe acute respiratory syndrome coronavirus 2.
32416289 2020. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.
32425332 2020. Neuroleptic malignant syndrome in a COVID-19 patient.
32531427 2020. Delirium as a presenting feature in COVID-19: neuroinvasive infection or autoimmune encephalopathy?
32525049 2020. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series.

32497778 2020. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.

32534982 2020. Incomplete and late recovery of sudden olfactory dysfunction in COVID-19.
32518103 2020. Guillain-Barre syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
32524707 2020. Smell and taste disorders during COVID-19 outbreak: A cross-sectional study on 355 patients.
32521062 2020. Headache as the Presenting Symptom in 2 Patients with COVID-19 and a History of Migraine: 2 Case Reports.
32521039 2020. COVID-19 and Headache: A Primer for Trainees.
32530326 2020. Does coronavirus affect the audio-vestibular system? A rapid systematic review.
32533876 2020. Guillain-Barre syndrome after SARS-CoV-2 infection.
32531083 2020. Guillain-Barre syndrome in a patient with antibodies against SARS-COV-2.
32526073 2020. Novel corona virus (COVID-19) disease and ophthalmic manifestations: Clinical evidences.
32454137 2020. Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report.
32445789 2020. Is COVID-19-related Guillain-Barre syndrome different?
32382727 2020. THE IMPACT OF COVID-19 ON MENTAL HEALTH: THE INTERACTIVE ROLES OF BRAIN BIOTYPES AND HUMAN CONNECTION.
32427134 2020. HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.
32447049 2020. Anosmia in COVID-19 patients.
32406140 2020. The ocular surface, coronaviruses and COVID-19.
32396988 2020. COVID-19, sweat, tears... and myopia?
32502645 2020. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
32525467 2020. COVID-19 and Acute Ischemic Stroke- A Case Series from Dubai, UAE.
32422545 2020. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
32405258 2020. Non-lesional status epilepticus in a patient with coronavirus disease 2019.
32422529 2020. Post SARS-CoV-2 Guillain-Barre syndrome.
32458242 2020. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis.
32531174 2020. New Insights for the Pathogenesis of COVID-19-Related Dysgeusia.
32499974 2020. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy, MRI Brain and Cerebrospinal Fluid Findings: Case 2.
32455089 2020. A Review of Neurological Complications of COVID-19.
32426749 2020. Neurologic Manifestations of Severe Respiratory Viral Contagions.
32428084 2020. Fonoaudiologia, amamentacao e COVID-19: informacoes aos fonoaudiologos.
32422426 2020. Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology.
32426200 2020. Encephalopathy as the Sentinel Sign of a Cortical Stroke in a Patient Infected With Coronavirus Disease-19 (COVID-19).
32528783 2020. Neurological and Psychological Effects of Coronavirus (COVID-19): An Overview of the Current Era Pandemic.
32494532 2020. Anosmia and Ageusia as the Only Indicators of Coronavirus Disease 2019 (COVID-19).
32489724 2020. Basal Ganglia Involvement and Altered Mental Status: A Unique Neurological Manifestation of Coronavirus Disease 2019.
32483497 2020. Novel Coronavirus Disease 2019 and Subarachnoid Hemorrhage: A Case Report.
32535934 2020. COVID-19 associated myositis with severe proximal and bulbar weakness.
32521557 2020. Riechstorungen bei COVID-19 - aktueller Wissensstand.
32534336 2020. COVID-19 & Periodontitis: The cytokine connection.
32515379 2020. Neurological manifestations of COVID-19.
32474399 2020. Infectivity of human coronavirus in the brain.
32468193 2020. Postintubation Dysphagia During COVID-19 Outbreak-Contemporary Review.
32533346 2020. Oropharyngeal Dysphagia and Aspiration Pneumonia Following Coronavirus Disease 2019: A Case Report.
32304092 2020. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study.
32491984 2020. Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020.
32489743 2020. COVID-19 Pandemic: A Neurological Perspective.
32399457 2020. Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.
32524689 2020. Overlapping findings or oral manifestations in new SARS-CoV-2 infection?

32523929 2020. Respiratory Distress in SARS-CoV-2 without Lung Damage: Phrenic Paralysis Should Be Considered in COVID-19 Infection.

32516281 2020. ANOSMIA AND AGEUSIA: NOT AN UNCOMMON PRESENTATION OF COVID-19 INFECTION IN CHILDREN AND ADOLESCENTS.
32396710 2020. COVID-19 and neurodegeneration: what can we learn from the past?
32383343 2020. Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection.
32463341 2020. COVID-19 and Eye Problems.
32513065 2020. Persistent Smell Loss Following Undetectable SARS-CoV-2.
32513055 2020. Comment on "The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis".
32470824 2020. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.
32424329 2020. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019.
32424327 2020. Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review.
32474035 2020. COVID-19 and the Eye.

32283878 2020. [Whether conjunctival congestion in patients infected with 2019 novel coronavirus is definitely related the novel coronavirus?]

32357379 2020. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine.

32515675 2020. Neurological Involvement of COVID-19 Patients: Making the Most of MRI.
32533768 2020. Time scale for resolution of olfactory dysfunction in COVID-19.
32437002 2020. Is the brain a reservoir organ for SARS-CoV2?
32383370 2020. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.
32476306 2020. Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report.
32383776 2020. Patient Follow-up after Discharge after COVID-19 Pneumonia: Considerations for Infectious Control.
32383264 2020. Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)".
32383174 2020. High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients.
32401352 2020. Update on the neurology of COVID-19.
32451846 2020. Does SARS-CoV-2 infection cause chronic neurological complications?
32398850 2020. Care for critically Ill patients with COVID-19: don't forget the eyes.
32521067 2020. Oral manifestations in COVID-19 patients.
32526743 2020. COVID-19-Related Stroke: Barking up the Wrong Tree?
32396239 2020. The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study.
32494854 2020. A review of pathophysiology and neuropsychiatric manifestations of COVID-19.
32462348 2020. Onset of Covid-19 with impaired consciousness and ataxia: a case report.
32458198 2020. Acute transverse myelitis after COVID-19 pneumonia.
32458197 2020. Neurological manifestations of COVID-19: a review of what we know so far.
32458195 2020. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19).
32458194 2020. Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19.
32458193 2020. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
32458192 2020. Post-infectious Guillain-Barre syndrome related to SARS-CoV-2 infection: a case report.
32451613 2020. Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19).
32436105 2020. Stroke in patients with SARS-CoV-2 infection: case series.
32430572 2020. Guillain-Barre syndrome in the COVID-19 era: just an occasional cluster?
32399694 2020. Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19.
32529462 2020. May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal.
32447746 2020. SARS-CoV-2 Infection Leads to Neurological Dysfunction.
32474657 2020. COVID-19-associated acute disseminated encephalomyelitis (ADEM).

32275082 2020. Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.

32533322 2020. Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection.
32533321 2020. Isolated post SARS-CoV-2 diplopia.
32529577 2020. COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF.
32529575 2020. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.
32494853 2020. Neurological complications of COVID-19: a preliminary review.
32436101 2020. Neurological manifestations associated with COVID-19: a review and a call for action.
32531579 2020. Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir.
32480073 2020. COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy.
32474220 2020. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion.
32532449 2020. Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19.
32474362 2020. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19.
32447193 2020. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome.
32444286 2020. Brain imaging findings in COVID-19: What do we know so far?
32417159 2020. Neuroradiological features in COVID-19 patients: First evidence in a complex scenario.
32437707 2020. Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence?
32424616 2020. A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.

32418055 2020. COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.
32529516 2020. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2.
32447630 2020. COVID-19 and the nervous system.
32423471 2020. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients.

Neurology, ophthalmology, orl

Aktuelle Version vom 12. September 2020, 17:22 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Meine Werkzeuge

Namensräume

Varianten

Ansichten

Aktionen

Suche

Navigation

Werkzeuge

@@ Zeile 1: / Zeile 1: @@
 {{pnc}}
+{{ft|D}}
 *'''[[Cerebral embolism]]'''
+*'''[[Cerebral Haemorrhage]]'''
 *'''[[Smell and taste disorder]]'''
 *'''[[Brain infection Neurotropism]]'''
@@ Zeile 6: / Zeile 9: @@
 *'''[[Autoimmune Neuropathies]]'''
 *'''[[Neurology Reviews and Multitopic]]'''
+*'''[[The morbid survivor]]''' late sequelae
 *'''[[Eye - Conjunctivitis]]'''
 *'''[[Eye - Reviews and Multitopic]]'''
+*'''[[ORL - any]]'''
-{{tp|p=32310553|t=2020. Ophthalmic Manifestations Of Coronavirus (COVID-19)|pdf=|usr=}}
+{{tp|p=32415003|t=2020. Do SARS-CoV2 viral proteins have neuromodulatory properties?|pdf=|usr=007}}
+{{tp|p=32490972|t=2020. COVID-19 and the eye: how much do we really know? A best evidence review.|pdf=|usr=007}}
+{{tp|p=32443834|t=2020. Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients.|pdf=|usr=007}}
 {{ttp|p=32348111|t=ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?|pdf=|usr=}}
-{{tp|p=32278470|t=ä. Upper airway symptoms in coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
-{{tp|p=32276732|t=ä. Hearing loss and COVID-19: A note |pdf=|usr=}}
-{{tp|p=32327217|t=ä. COVID-19 and hearing difficulties |pdf=|usr=}}
-{{tp|p=32345855|t=2020. Coronavirus Disease 2019 Pandemic Acute Respiratory Distress Syndrome Survivors:  Pain After the Storm?|pdf=|usr=}}
-{{tp|p=32265202|t=2020. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease |pdf=|usr=}}
-{{tp|p=32298803|t=ä. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms? |pdf=|usr=}}
 {{tp|p=32322822|t=ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC |pdf=|usr=}}
-{{tp|p=32283246|t=ä. Treating the Mental Health Effects of COVID-19: The Need for At-Home Neurotherapeutics Is Now |pdf=|usr=}}
 {{tp|p=32328364|t=ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy |pdf=|usr=}}
-{{tp|p=32283980|t=2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms |pdf=|usr=}}
 {{tp|p=32370982|t=ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review |pdf=|usr=}}
-{{tp|p=32362868|t=2020. Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic |pdf=|usr=}}
-{{tp|p=32328758|t=ä. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value  of ocular tissue/fluid |pdf=|usr=}}
 {{tp|p=32363146|t=2020. COVID-19 Presenting with Seizures |pdf=|usr=}}
-{{tp|p=32314322|t=ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights |pdf=|usr=}}
 {{tp|p=32307298|t=ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis |pdf=|usr=}}
-{{tp|p=32334847|t=ä. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): interest of telemedicine during the pandemic context |pdf=|usr=}}
-{{tp|p=32165057|t=2020. Le nouveau Coronavirus Covid-19: quels risques ophtalmiques?|pdf=|usr=}}
 {{tp|p=32232433|t=2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China |pdf=|usr=}}
-{{tp|p=32361098|t=2020. Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?|pdf=|usr=}}
-{{tp|p=32322398|t=2020. COVID-19 and intracerebral haemorrhage: causative or coincidental?|pdf=|usr=}}
-{{tp|p=32175797|t=2020. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals |pdf=|usr=}}
-{{tp|p=32359841|t=ä. A Rashomon Moment? Ocular Involvement and COVID-19 |pdf=|usr=}}
-{{tp|p=32246403|t=ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion |pdf=|usr=}}
 {{tp|p=32344366|t=2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report |pdf=|usr=}}
+{{tp|p=32478706|t=2020. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?|pdf=|usr=007}}
-{{tp|p=32378854|t=2020. Covid-19 med nedsatt lukte- og smakssans som eneste symptom |pdf=|usr=}}
-{{tp|p=32359765|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System |pdf=|usr=}}
 {{tp|p=32374367|t=ä. Delirium: a missing piece in the COVID-19 pandemic puzzle |pdf=|usr=}}
-{{tp|p=32336042|t=2020. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19 |pdf=|usr=}}
-{{tp|p=32086236|t=2020. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear |pdf=|usr=}}
-{{tp|p=32379592|t=2020. Emerging evidence for neuropsycho-consequences of COVID-19 |pdf=|usr=}}
 {{tp|p=32333819|t=2020. COVID-19: what if the brain had a role in causing the deaths?|pdf=|usr=}}
 {{ttp|p=32301553|t=2020. Lack of dyspnea in patients with Covid-19: another neurological conundrum?|pdf=|usr=}}
 {{ttp|p=32246784|t=ä. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID?19 |pdf=|usr=}}
-{{tp|p=32352575|t=2020. Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients" |pdf=|usr=}}
 {{tp|p=32246782|t=2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2 |pdf=|usr=}}
-{{tp|p=32267483|t=2020. Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19 |pdf=|usr=}}
 {{tp|p=32291797|t=2020. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration |pdf=|usr=}}
+{{ttp|p=32388138|t=2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection |pdf=|usr=}}
+{{tp|p=32342265|t=ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome |pdf=|usr=}}
+{{tp|p=32457227|t=2020. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.|pdf=|usr=007}}
+{{tp|p=32390132|t=2020. Trombosis venosa cerebral e infeccion por SARS-CoV-2.|pdf=|usr=007}}
+{{tp|p=32482781|t=2020. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.|pdf=|usr=007}}
+{{tp|p=32461235|t=2020. Guillain-Barre syndrome related to SARS-CoV-2 infection.|pdf=|usr=007}}
+{{tp|p=32444427|t=2020. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?|pdf=|usr=007}}
+{{tp|p=32386285|t=2020. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.|pdf=|usr=007}}
+{{tp|p=32352450|t=2020. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.|pdf=|usr=007}}
+{{tp|p=32463395|t=2020. The involvement of the central nervous system in patients with COVID-19.|pdf=|usr=007}}
+{{tp|p=32355007|t=2020. The mystery of the pandemic's 'happy hypoxia'.|pdf=|usr=007}}
+{{tp|p=32286214|t=2020. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].|pdf=|usr=007}}
+{{tp|p=32400371|t=2020. [Anosmia and ageusia as primary symptoms of COVID-19].|pdf=|usr=007}}
+{{tp|p=32476394|t=2020. Otorinolaringologicheskie aspekty techeniya zabolevaniya u detei, infitsirovannykh virusom SARS-CoV-2.|pdf=|usr=007}}
+{{tp|p=32468632|t=2020. Olfactory dysfunction in recovered COVID-19 patients.|pdf=|usr=007}}
+{{tp|p=32512352|t=2020. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.|pdf=|usr=007}}
+{{tp|p=32442268|t=2020. Stroke in a young COVID -19 patient.|pdf=|usr=007}}
+{{tp|p=32484418|t=2020. Focal Cerebral Arteriopathy in a COVID-19 Pediatric Patient.|pdf=|usr=007}}
+{{tp|p=32437314|t=2020. COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages.|pdf=|usr=007}}
+{{tp|p=32437313|t=2020. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: An Italian Multicenter Retrospective Observational Study.|pdf=|usr=007}}
+{{tp|p=32407258|t=2020. COVID-19-Associated Leukoencephalopathy.|pdf=|usr=007}}
+{{tp|p=32510821|t=2020. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor.|pdf=|usr=007}}
+{{tp|p=32506730|t=2020. Oral Manifestations in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
+{{tp|p=32506662|t=2020. Necrotizing periodontal disease: oral manifestation of COVID-19.|pdf=|usr=007}}
+{{tp|p=32419568|t=2020. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.|pdf=|usr=007}}
+{{tp|p=32453685|t=2020. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.|pdf=|usr=007}}
+{{tp|p=32490966|t=2020. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.|pdf=|usr=007}}
+{{tp|p=32469246|t=2020. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.|pdf=|usr=007}}
+{{tp|p=32436441|t=2020. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.|pdf=|usr=007}}
+{{tp|p=32423359|t=2020. Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.|pdf=|usr=007}}
+{{tp|p=32423285|t=2020. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses.|pdf=|usr=007}}
+{{tp|p=32502296|t=2020. SARS-CoV2 as a potential trigger of neurodegenerative diseases.|pdf=|usr=007}}
+{{tp|p=32502289|t=2020. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead.|pdf=|usr=007}}
+{{tp|p=32348051|t=2020. Anosmie et COVID-19.|pdf=|usr=007}}
+{{tp|p=32501861|t=2020. Considering the potential for an increase in chronic pain following the COVID-19 pandemic.|pdf=|usr=007}}
+{{tp|p=32404789|t=2020. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms.|pdf=|usr=007}}
+{{tp|p=32468450|t=2020. New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases.|pdf=|usr=007}}
+{{tp|p=32444493|t=2020. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.|pdf=|usr=007}}
+{{tp|p=32444492|t=2020. Bilateral transient olfactory bulbs edema during COVID-19-related anosmia.|pdf=|usr=007}}
+{{tp|p=32439822|t=2020. Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection.|pdf=|usr=007}}
+{{tp|p=32439821|t=2020. Generalized myoclonus in COVID-19.|pdf=|usr=007}}
+{{tp|p=32487714|t=2020. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.|pdf=|usr=007}}
+{{tp|p=32482845|t=2020. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.|pdf=|usr=007}}
+{{tp|p=32424429|t=2020. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.|pdf=|usr=007}}
+{{tp|p=32496534|t=2020. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients.|pdf=|usr=007}}
+{{tp|p=32490520|t=2020. Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients.|pdf=|usr=007}}
+{{ttp|p=32392566|t=2020. The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack.|pdf=|usr=007}}
+{{tp|p=32487282|t=2020. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.|pdf=|usr=007}}
+{{tp|p=32445201|t=2020. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia.|pdf=|usr=007}}
+{{tp|p=32505222|t=2020. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.|pdf=|usr=007}}
+{{tp|p=32503883|t=2020. Defining causality in COVID-19 and neurological disorders.|pdf=|usr=007}}
+{{tp|p=32507577|t=2020. COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.|pdf=|usr=007}}
+{{tp|p=32458578|t=2020. COVID-19 encephalopathy masquerading as substance withdrawal.|pdf=|usr=007}}
+{{tp|p=32453517|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.|pdf=|usr=007}}
+{{tp|p=32453516|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=007}}
+{{tp|p=32453515|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=007}}
+{{tp|p=32497292|t=2020. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection.|pdf=|usr=007}}
+{{tp|p=32432682|t=2020. Olfactory Dysfunction in COVID-19: Diagnosis and Management.|pdf=|usr=007}}
+{{tp|p=32469387|t=2020. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.|pdf=|usr=007}}
+{{tp|p=32497288|t=2020. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.|pdf=|usr=007}}
+{{tp|p=32504746|t=2020. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.|pdf=|usr=007}}
+{{tp|p=32427357|t=2020. Encephalopathy in patients with COVID-19: 'Causality or coincidence?'|pdf=|usr=007}}
+{{tp|p=32418237|t=2020. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".|pdf=|usr=007}}
+{{tp|p=32484990|t=2020. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.|pdf=|usr=007}}
+{{tp|p=32451359|t=2020. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.|pdf=|usr=007}}
+{{tp|p=32492193|t=2020. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
+{{tp|p=32504100|t=2020. Ocular manifestations of coronavirus disease 2019.|pdf=|usr=007}}
+{{tp|p=32437033|t=2020. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.|pdf=|usr=007}}
+{{tp|p=32437022|t=2020. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.|pdf=|usr=007}}
+{{tp|p=32507468|t=2020. Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment.|pdf=|usr=007}}
+{{tp|p=32461325|t=2020. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.|pdf=|usr=007}}
+{{tp|p=32406374|t=2020. Olfactory dysfunction in the COVID-19 outbreak.|pdf=|usr=007}}
+{{tp|p=32505878|t=2020. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.|pdf=|usr=007}}
+{{tp|p=32412510|t=2020. Neurological manifestations of COVID-19.|pdf=|usr=007}}
+{{tp|p=32398625|t=2020. Coincidence of COVID-19 Infection and Smell: Taste Perception Disorders.|pdf=|usr=007}}
+{{tp|p=32505431|t=2020. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.|pdf=|usr=007}}
+{{tp|p=32505432|t=2020. Does COVID-19 cause axonal GBS?|pdf=|usr=007}}
+{{tp|p=32436835|t=2020. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.|pdf=|usr=007}}
+{{tp|p=32408926|t=2020. Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?|pdf=|usr=007}}
+{{tp|p=32501751|t=2020. EXPRESS: Brain ischemic and hemorrhagic complications of COVID-19.|pdf=|usr=007}}
+{{tp|p=32497397|t=2020. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients?|pdf=|usr=007}}
+{{tp|p=32496658|t=2020. Reply to: Psychophysical olfactory testing in COVID-19: Is smell function really impaired in nearly all patients?|pdf=|usr=007}}
+{{tp|p=32503820|t=2020. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.|pdf=|usr=007}}
+{{tp|p=32441248|t=2020. The impact of SARS-CoV-2 on sleep.|pdf=|usr=007}}
+{{tp|p=32507123|t=2020. Self-reported anosmia and dysgeusia as key symptoms of COVID-19.|pdf=|usr=007}}
+{{tp|p=32478675|t=2020. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
+{{tp|p=32460415|t=2020. Dysphagia in COVID-19 -multilevel damage to the swallowing network?|pdf=|usr=007}}
+{{tp|p=32433817|t=2020. Prolonged Confusional state as first manifestation of COVID-19.|pdf=|usr=007}}
+{{tp|p=32503088|t=2020. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.|pdf=|usr=007}}
+{{tp|p=32503084|t=2020. Miller-Fisher syndrome after SARS-CoV-2 infection.|pdf=|usr=007}}
+{{tp|p=32503080|t=2020. Concomitant brain arterial and venous thrombosis in a COVID-19 patient.|pdf=|usr=007}}
+{{tp|p=32492256|t=2020. How to support the quality of life of people living with cognitive disorders? A (k)new challenge in the post-Covid World.|pdf=|usr=007}}
+{{tp|p=32478936|t=2020. SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with favorable outcome.|pdf=|usr=007}}
+{{tp|p=32450718|t=2020. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?|pdf=|usr=007}}
+{{tp|p=32443166|t=2020. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).|pdf=|usr=007}}
+{{tp|p=32449247|t=2020. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study.|pdf=|usr=007}}
+{{tp|p=32416028|t=2020. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.|pdf=|usr=007}}
+{{tp|p=32468862|t=2020. L..: malignant MCA infarct in a patient with COVID 19 infection.|pdf=|usr=007}}
+{{tp|p=32463454|t=2020. Alterations in smell or taste - Classic COVID-19?|pdf=|usr=007}}
+{{tp|p=32436625|t=2020. Low risk of SARS-CoV-2 transmission through the ocular surface.|pdf=|usr=007}}
+{{tp|p=32484130|t=2020. COVID-19 associated central nervous system vasculopathy.|pdf=|usr=007}}
+{{tp|p=32474587|t=2020. COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.|pdf=|usr=007}}
+{{tp|p=32491829|t=2020. SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis.|pdf=|usr=007}}
+{{tp|p=32421258|t=2020. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.|pdf=|usr=007}}
+{{tp|p=32403983|t=2020. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children.|pdf=|usr=007}}
+{{tp|p=32468972|t=2020. Guillain-Barre syndrome with facial diplegia related to SARS-CoV-2 infection.|pdf=|usr=007}}
+{{tp|p=32493536|t=2020. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy.|pdf=|usr=007}}
+{{tp|p=32473022|t=2020. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.|pdf=|usr=007}}
+{{tp|p=32420954|t=2020. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.|pdf=|usr=007}}
+{{tp|p=32413158|t=2020. Headaches During COVID-19: My Clinical Case and Review of the Literature.|pdf=|usr=008}}
+{{tp|p=32470238|t=2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection.|pdf=|usr=007}}
+{{tp|p=32451564|t=2020. Temporare Hyposmie bei COVID-19-Patienten.|pdf=|usr=008}}
+{{tp|p=32426230|t=2020. Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient.|pdf=|usr=008}}
+{{tp|p=32467191|t=2020. Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States.|pdf=|usr=007}}
+{{tp|p=32467190|t=2020. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.|pdf=|usr=007}}
+{{tp|p=32467189|t=2020. Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.|pdf=|usr=007}}
+{{tp|p=32439646|t=2020. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.|pdf=|usr=007}}
+{{tp|p=32409316|t=2020. Cerebrovascular Disease in COVID-19.|pdf=|usr=007}}
+{{tp|p=32354715|t=2020. Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.|pdf=|usr=007}}
+{{tp|p=32483943|t=2020. Episcleritis as an ocular manifestation in a patient with COVID-19.|pdf=|usr=007}}
+{{tp|p=32514394|t=2020. Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
+{{tp|p=32519260|t=2020. Thalassemic Child Presenting with Anosmia due to COVID-19.|pdf=|usr=008}}
+{{tp|p=32461419|t=2020. Commentary: Exploring the transmission of COVID-19 through the ocular surface.|pdf=|usr=008}}
+{{tp|p=32461418|t=2020. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients.|pdf=|usr=008}}
+{{tp|p=32410112|t=2020. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients.|pdf=|usr=008}}
+{{tp|p=32532937|t=2020. Neurologic aspects of covid-19: a concise review.|pdf=|usr=008}}
+{{tp|p=32425285|t=2020. Retrospective Analysis of Smell and Taste Disturbances Associated with Dermatological Medications Reported to the United States Food and Drug Administration and Relevance to COVID-19 Infections.|pdf=|usr=008}}
+{{tp|p=32535294|t=2020. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.|pdf=|usr=008}}
+{{tp|p=32363809|t=2020. Smell and taste symptom-based predictive model for COVID-19 diagnosis.|pdf=|usr=008}}
+{{tp|p=32410386|t=2020. Smell and taste alterations in Covid-19: a cross-sectional analysis of different cohorts.|pdf=|usr=008}}
+{{tp|p=32395917|t=2020. Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor?|pdf=|usr=008}}
+{{tp|p=32395913|t=2020. Reply to: Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor?|pdf=|usr=008}}
+{{tp|p=32271490|t=2020. A primer on viral-associated olfactory loss in the era of COVID-19.|pdf=|usr=008}}
+{{tp|p=32279441|t=2020. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.|pdf=|usr=008}}
+{{tp|p=32526392|t=2020. Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?|pdf=|usr=008}}
+{{tp|p=32531341|t=2020. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report.|pdf=|usr=008}}
+{{tp|p=32410788|t=2020. Facial diplegia, a possible atypical variant of Guillain-Barre Syndrome as a rare neurological complication of SARS-CoV-2.|pdf=|usr=008}}
+{{tp|p=32456959|t=2020. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.|pdf=|usr=008}}
+{{tp|p=32453100|t=2020. Novel Coronavirus (COVID-19)-Associated Guillain-Barre Syndrome: Case Report.|pdf=|usr=008}}
+{{tp|p=32519322|t=2020. Self-Reported Loss of Smell and Taste in SARS-CoV-2 Patients: Primary Care Data to Guide Future Early Detection Strategies.|pdf=|usr=008}}
+{{tp|p=32425479|t=2020. MRI evaluation of the olfactory clefts in patients with SARS-CoV-2 infection revealed an unexpected mechanism for olfactory function loss.|pdf=|usr=008}}
+{{ttp|p=32427468|t=2020. Autonomic Brain Centers and Pathophysiology of COVID-19.|pdf=|usr=008}}
+{{tp|p=32524537|t=2020. A complication of coronavirus disease 2019: delirium.|pdf=|usr=008}}
+{{tp|p=32430637|t=2020. COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report.|pdf=|usr=008}}
+{{tp|p=32412088|t=2020. Neurological Manifestations of COVID-19: A systematic review and current update.|pdf=|usr=008}}
+{{tp|p=32466862|t=2020. Alteraciones del olfato en la COVID-19, revision de la evidencia e implicaciones en el manejo de la pandemia.|pdf=|usr=008}}
+{{tp|p=32527987|t=2020. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients.|pdf=|usr=008}}
+{{tp|p=32519994|t=2020. Vertigo and hearing loss during the COVID-19 pandemic - is there an association?|pdf=|usr=008}}
+{{tp|p=32414522|t=2020. Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
+{{tp|p=32506549|t=2020. COVID-19: A Global Threat to the Nervous System.|pdf=|usr=008}}
+{{tp|p=32425470|t=2020. Altered Mental Status as a Novel Initial Clinical Presentation for COVID-19 Infection in the Elderly.|pdf=|usr=008}}
+{{tp|p=32527141|t=2020. Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study.|pdf=|usr=008}}
+{{tp|p=32473756|t=2020. Neuroleptic malignant syndrome in patients with COVID-19.|pdf=|usr=008}}
+{{tp|p=32425321|t=2020. Neurologic complications of COVID-19.|pdf=|usr=008}}
+{{tp|p=32530597|t=2020. Happy Hypoxemia in COVID-19-A Neural Hypothesis.|pdf=|usr=008}}
+{{tp|p=32531619|t=2020. Olfactory and gustatory dysfunctions in COVID-19. First reports of Latin-American ethnic patients.|pdf=|usr=008}}
+{{tp|p=32527845|t=2020. Evolving Neuroimaging Findings during COVID-19.|pdf=|usr=008}}
+{{tp|p=32527844|t=2020. Neurovascular Complications in COVID-19 Infection: Case Series.|pdf=|usr=008}}
+{{tp|p=32527843|t=2020. Neuroimaging Findings in Patients with COVID-19.|pdf=|usr=008}}
+{{tp|p=32527842|t=2020. Neurologic Involvement in COVID-19: Cause or Coincidence? A Neuroimaging Perspective.|pdf=|usr=008}}
+{{tp|p=32388880|t=2020. Guillain-Barre syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.|pdf=|usr=008}}
+{{tp|p=32395550|t=2020. 2019 novel coronavirus pneumonia with onset of dizziness: a case report.|pdf=|usr=008}}
+{{tp|p=32418288|t=2020. Steroid-Responsive Encephalitis in Coronavirus Disease 2019.|pdf=|usr=008}}
+{{tp|p=32395831|t=2020. Rapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19.|pdf=|usr=008}}
+{{tp|p=32419756|t=2020. Alteration of Consciousness as Initial Presentation in COVID-19: Observation.|pdf=|usr=008}}
+{{tp|p=32419755|t=2020. COVID-19 and Epilepsy.|pdf=|usr=008}}
+{{tp|p=32419754|t=2020. COVID-19 and Underlying Cerebrovascular Disease: Analysis on Association.|pdf=|usr=008}}
+{{tp|p=32419753|t=2020. COVID 19: Neuromuscular Manifestations.|pdf=|usr=008}}
+{{tp|p=32419751|t=2020. 2019-NCoV: What Every Neurologist Should Know?|pdf=|usr=008}}
+{{tp|p=32407609|t=2020. De Novo Status Epilepticus in patients with COVID-19.|pdf=|usr=008}}
+{{tp|p=32410763|t=2020. Acute olfactory loss is specific for Covid-19 at the Emergency Department.|pdf=|usr=008}}
+{{tp|p=32516656|t=2020. Clinical characteristics associated with persistent olfactory and taste alterations in COVID-19: A preliminary report on 121 patients.|pdf=|usr=008}}
+{{tp|p=32336572|t=2020. New type of corona virus induced acute otitis media in adult.|pdf=|usr=008}}
+{{tp|p=32307189|t=2020. Audiological profile of asymptomatic Covid-19 PCR-positive cases.|pdf=|usr=008}}
+{{tp|p=32526530|t=2020. COVID-19 sampling from the middle ear and mastoid: A case report.|pdf=|usr=008}}
+{{tp|p=32386897|t=2020. Comment on "Hearing loss and COVID-19: A note".|pdf=|usr=008}}
+{{tp|p=32471704|t=2020. Central Nervous System Involvement in COVID-19.|pdf=|usr=008}}
+{{tp|p=32517875|t=2020. Epidemia COVID-19: inverted question markdebe el oftalmologo estar alerta ante las paresias oculomotoras?|pdf=|usr=008}}
+{{tp|p=32404376|t=2020. Hypogeusia as the initial presenting symptom of COVID-19.|pdf=|usr=008}}
+{{tp|p=32449883|t=2020. Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19.|pdf=|usr=008}}
+{{tp|p=32533727|t=2020. Report of EEG Finding on Critically Ill Patients with COVID-19.|pdf=|usr=008}}
+{{tp|p=32468830|t=2020. Taste and Smell Dysfunction in COVID-19 Patients.|pdf=|usr=008}}
+{{tp|p=32530389|t=2020. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease (COVID-19).|pdf=|usr=008}}
+{{tp|p=32479992|t=2020. Identifying causal role of COVID-19 in immunopsychiatry models.|pdf=|usr=008}}
+{{tp|p=32497777|t=2020. The neuroinvasive potential of severe acute respiratory syndrome coronavirus 2.|pdf=|usr=008}}
+{{tp|p=32416289|t=2020. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.|pdf=|usr=008}}
+{{tp|p=32425332|t=2020. Neuroleptic malignant syndrome in a COVID-19 patient.|pdf=|usr=008}}
+{{tp|p=32531427|t=2020. Delirium as a presenting feature in COVID-19: neuroinvasive infection or autoimmune encephalopathy?|pdf=|usr=008}}
+{{tp|p=32525049|t=2020. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series.|pdf=|usr=008}}
+{{ttp|p=32497778|t=2020. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.|pdf=|usr=008}}
+{{tp|p=32534982|t=2020. Incomplete and late recovery of sudden olfactory dysfunction in COVID-19.|pdf=|usr=008}}
+{{tp|p=32518103|t=2020. Guillain-Barre syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.|pdf=|usr=008}}
+{{tp|p=32524707|t=2020. Smell and taste disorders during COVID-19 outbreak: A cross-sectional study on 355 patients.|pdf=|usr=008}}
+{{tp|p=32521062|t=2020. Headache as the Presenting Symptom in 2 Patients with COVID-19 and a History of Migraine: 2 Case Reports.|pdf=|usr=008}}
+{{tp|p=32521039|t=2020. COVID-19 and Headache: A Primer for Trainees.|pdf=|usr=008}}
+{{tp|p=32530326|t=2020. Does coronavirus affect the audio-vestibular system? A rapid systematic review.|pdf=|usr=008}}
+{{tp|p=32533876|t=2020. Guillain-Barre syndrome after SARS-CoV-2 infection.|pdf=|usr=008}}
+{{tp|p=32531083|t=2020. Guillain-Barre syndrome in a patient with antibodies against SARS-COV-2.|pdf=|usr=008}}
+{{tp|p=32526073|t=2020. Novel corona virus (COVID-19) disease and ophthalmic manifestations: Clinical evidences.|pdf=|usr=008}}
+{{tp|p=32454137|t=2020. Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report.|pdf=|usr=008}}
+{{tp|p=32445789|t=2020. Is COVID-19-related Guillain-Barre syndrome different?|pdf=|usr=008}}
+{{tp|p=32382727|t=2020. THE IMPACT OF COVID-19 ON MENTAL HEALTH: THE INTERACTIVE ROLES OF BRAIN BIOTYPES AND HUMAN CONNECTION.|pdf=|usr=008}}
+{{tp|p=32427134|t=2020. HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.|pdf=|usr=008}}
+{{tp|p=32447049|t=2020. Anosmia in COVID-19 patients.|pdf=|usr=008}}
+{{tp|p=32406140|t=2020. The ocular surface, coronaviruses and COVID-19.|pdf=|usr=008}}
+{{tp|p=32396988|t=2020. COVID-19, sweat, tears... and myopia?|pdf=|usr=008}}
+{{tp|p=32502645|t=2020. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.|pdf=|usr=008}}
+{{tp|p=32525467|t=2020. COVID-19 and Acute Ischemic Stroke- A Case Series from Dubai, UAE.|pdf=|usr=008}}
+{{tp|p=32422545|t=2020. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.|pdf=|usr=008}}
+{{tp|p=32405258|t=2020. Non-lesional status epilepticus in a patient with coronavirus disease 2019.|pdf=|usr=008}}
+{{tp|p=32422529|t=2020. Post SARS-CoV-2 Guillain-Barre syndrome.|pdf=|usr=008}}
+{{tp|p=32458242|t=2020. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis.|pdf=|usr=008}}
+{{tp|p=32531174|t=2020. New Insights for the Pathogenesis of COVID-19-Related Dysgeusia.|pdf=|usr=008}}
+{{tp|p=32499974|t=2020. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy, MRI Brain and Cerebrospinal Fluid Findings: Case 2.|pdf=|usr=008}}
+{{tp|p=32455089|t=2020. A Review of Neurological Complications of COVID-19.|pdf=|usr=008}}
+{{tp|p=32426749|t=2020. Neurologic Manifestations of Severe Respiratory Viral Contagions.|pdf=|usr=008}}
+{{tp|p=32428084|t=2020. Fonoaudiologia, amamentacao e COVID-19: informacoes aos fonoaudiologos.|pdf=|usr=008}}
+{{tp|p=32422426|t=2020. Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology.|pdf=|usr=008}}
+{{tp|p=32426200|t=2020. Encephalopathy as the Sentinel Sign of a Cortical Stroke in a Patient Infected With Coronavirus Disease-19 (COVID-19).|pdf=|usr=008}}
+{{tp|p=32528783|t=2020. Neurological and Psychological Effects of Coronavirus (COVID-19): An Overview of the Current Era Pandemic.|pdf=|usr=008}}
+{{tp|p=32494532|t=2020. Anosmia and Ageusia as the Only Indicators of Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
+{{tp|p=32489724|t=2020. Basal Ganglia Involvement and Altered Mental Status: A Unique Neurological Manifestation of Coronavirus Disease 2019.|pdf=|usr=008}}
+{{tp|p=32483497|t=2020. Novel Coronavirus Disease 2019 and Subarachnoid Hemorrhage: A Case Report.|pdf=|usr=008}}
+{{tp|p=32535934|t=2020. COVID-19 associated myositis with severe proximal and bulbar weakness.|pdf=|usr=008}}
+{{tp|p=32521557|t=2020. Riechstorungen bei COVID-19 - aktueller Wissensstand.|pdf=|usr=008}}
+{{tp|p=32534336|t=2020. COVID-19 & Periodontitis: The cytokine connection.|pdf=|usr=008}}
+{{tp|p=32515379|t=2020. Neurological manifestations of COVID-19.|pdf=|usr=008}}
+{{tp|p=32474399|t=2020. Infectivity of human coronavirus in the brain.|pdf=|usr=008}}
+{{tp|p=32468193|t=2020. Postintubation Dysphagia During COVID-19 Outbreak-Contemporary Review.|pdf=|usr=008}}
+{{tp|p=32533346|t=2020. Oropharyngeal Dysphagia and Aspiration Pneumonia Following Coronavirus Disease 2019: A Case Report.|pdf=|usr=008}}
+{{tp|p=32304092|t=2020. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study.|pdf=|usr=008}}
+{{tp|p=32491984|t=2020. Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020.|pdf=|usr=008}}
+{{tp|p=32489743|t=2020. COVID-19 Pandemic: A Neurological Perspective.|pdf=|usr=008}}
+{{tp|p=32399457|t=2020. Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.|pdf=|usr=008}}
+{{tp|p=32524689|t=2020. Overlapping findings or oral manifestations in new SARS-CoV-2 infection?|pdf=|usr=008}}
+{{ttp|p=32523929|t=2020. Respiratory Distress in SARS-CoV-2 without Lung Damage: Phrenic Paralysis Should Be Considered in COVID-19 Infection.|pdf=|usr=008}}
+{{tp|p=32516281|t=2020. ANOSMIA AND AGEUSIA: NOT AN UNCOMMON PRESENTATION OF COVID-19 INFECTION IN CHILDREN AND ADOLESCENTS.|pdf=|usr=008}}
+{{tp|p=32396710|t=2020. COVID-19 and neurodegeneration: what can we learn from the past?|pdf=|usr=008}}
+{{tp|p=32383343|t=2020. Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection.|pdf=|usr=008}}
+{{tp|p=32463341|t=2020. COVID-19 and Eye Problems.|pdf=|usr=008}}
+{{tp|p=32513065|t=2020. Persistent Smell Loss Following Undetectable SARS-CoV-2.|pdf=|usr=008}}
+{{tp|p=32513055|t=2020. Comment on "The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis".|pdf=|usr=008}}
+{{tp|p=32470824|t=2020. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.|pdf=|usr=008}}
+{{tp|p=32424329|t=2020. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019.|pdf=|usr=008}}
+{{tp|p=32424327|t=2020. Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review.|pdf=|usr=008}}
+{{tp|p=32474035|t=2020. COVID-19 and the Eye.|pdf=|usr=008}}
-{{tp|p=32380269|t=ä. The COVID-19 pandemic: consideration for brain infection |pdf=|usr=}}
+{{tp|p=32283878|t=2020. [Whether conjunctival congestion in patients infected with 2019 novel coronavirus is definitely related the novel coronavirus?]|pdf=|usr=008}}
+{{tp|p=32357379|t=2020. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine.|pdf=|usr=008}}
+{{tp|p=32515675|t=2020. Neurological Involvement of COVID-19 Patients: Making the Most of MRI.|pdf=|usr=008}}
+{{tp|p=32533768|t=2020. Time scale for resolution of olfactory dysfunction in COVID-19.|pdf=|usr=008}}
+{{tp|p=32437002|t=2020. Is the brain a reservoir organ for SARS-CoV2?|pdf=|usr=008}}
+{{tp|p=32383370|t=2020. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.|pdf=|usr=008}}
+{{tp|p=32476306|t=2020. Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report.|pdf=|usr=008}}
+{{tp|p=32383776|t=2020. Patient Follow-up after Discharge after COVID-19 Pneumonia: Considerations for Infectious Control.|pdf=|usr=008}}
+{{tp|p=32383264|t=2020. Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)".|pdf=|usr=008}}
+{{tp|p=32383174|t=2020. High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients.|pdf=|usr=008}}
+{{tp|p=32401352|t=2020. Update on the neurology of COVID-19.|pdf=|usr=008}}
+{{tp|p=32451846|t=2020. Does SARS-CoV-2 infection cause chronic neurological complications?|pdf=|usr=008}}
+{{tp|p=32398850|t=2020. Care for critically Ill patients with COVID-19: don't forget the eyes.|pdf=|usr=008}}
+{{tp|p=32521067|t=2020. Oral manifestations in COVID-19 patients.|pdf=|usr=008}}
+{{tp|p=32526743|t=2020. COVID-19-Related Stroke: Barking up the Wrong Tree?|pdf=|usr=008}}
+{{tp|p=32396239|t=2020. The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study.|pdf=|usr=008}}
+{{tp|p=32494854|t=2020. A review of pathophysiology and neuropsychiatric manifestations of COVID-19.|pdf=|usr=008}}
+{{tp|p=32462348|t=2020. Onset of Covid-19 with impaired consciousness and ataxia: a case report.|pdf=|usr=008}}
+{{tp|p=32458198|t=2020. Acute transverse myelitis after COVID-19 pneumonia.|pdf=|usr=008}}
+{{tp|p=32458197|t=2020. Neurological manifestations of COVID-19: a review of what we know so far.|pdf=|usr=008}}
+{{tp|p=32458195|t=2020. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19).|pdf=|usr=008}}
+{{tp|p=32458194|t=2020. Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19.|pdf=|usr=008}}
+{{tp|p=32458193|t=2020. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.|pdf=|usr=008}}
+{{tp|p=32458192|t=2020. Post-infectious Guillain-Barre syndrome related to SARS-CoV-2 infection: a case report.|pdf=|usr=008}}
+{{tp|p=32451613|t=2020. Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19).|pdf=|usr=008}}
+{{tp|p=32436105|t=2020. Stroke in patients with SARS-CoV-2 infection: case series.|pdf=|usr=008}}
+{{tp|p=32430572|t=2020. Guillain-Barre syndrome in the COVID-19 era: just an occasional cluster?|pdf=|usr=008}}
+{{tp|p=32399694|t=2020. Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19.|pdf=|usr=008}}
+{{tp|p=32529462|t=2020. May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal.|pdf=|usr=008}}
+{{tp|p=32447746|t=2020. SARS-CoV-2 Infection Leads to Neurological Dysfunction.|pdf=|usr=008}}
+{{tp|p=32474657|t=2020. COVID-19-associated acute disseminated encephalomyelitis (ADEM).|pdf=|usr=008}}
-{{tp|p=32369434|t=2020. Acute Parotitis: A Possible Precocious Clinical Manifestation of SARS-CoV-2 Infection?|pdf=|usr=}}
-{{tp|p=32228363|t=2020. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features |pdf=|usr=}}
+{{tp|p=32275082|t=2020. Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.|pdf=|usr=008}}
-{{tp|p=32338254|t=2020. Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss |pdf=|usr=}}
-{{tp|p=32319971|t=2020. Anosmia as a prominent symptom of COVID-19 infection |pdf=|usr=}}
-{{tp|p=32240279|t=2020. Isolated sudden onset anosmia in COVID-19 infection  A novel syndrome?|pdf=|usr=}}
-{{tp|p=32277751|t=2020. Presentation of new onset anosmia during the COVID-19 pandemic |pdf=|usr=}}
+{{tp|p=32533322|t=2020. Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection.|pdf=|usr=008}}
+{{tp|p=32533321|t=2020. Isolated post SARS-CoV-2 diplopia.|pdf=|usr=008}}
+{{tp|p=32529577|t=2020. COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF.|pdf=|usr=008}}
+{{tp|p=32529575|t=2020. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.|pdf=|usr=008}}
+{{tp|p=32494853|t=2020. Neurological complications of COVID-19: a preliminary review.|pdf=|usr=008}}
+{{tp|p=32436101|t=2020. Neurological manifestations associated with COVID-19: a review and a call for action.|pdf=|usr=008}}
+{{tp|p=32531579|t=2020. Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir.|pdf=|usr=008}}
+{{tp|p=32480073|t=2020. COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy.|pdf=|usr=008}}
+{{tp|p=32474220|t=2020. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion.|pdf=|usr=008}}
+{{tp|p=32532449|t=2020. Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19.|pdf=|usr=008}}
+{{tp|p=32474362|t=2020. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19.|pdf=|usr=008}}
+{{tp|p=32447193|t=2020. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome.|pdf=|usr=008}}
+{{tp|p=32444286|t=2020. Brain imaging findings in COVID-19: What do we know so far?|pdf=|usr=008}}
+{{tp|p=32417159|t=2020. Neuroradiological features in COVID-19 patients: First evidence in a complex scenario.|pdf=|usr=008}}
+{{tp|p=32437707|t=2020. Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence?|pdf=|usr=008}}
+{{tp|p=32424616|t=2020. A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.|pdf=|usr=008}}
+{{tp|p=32418055|t=2020. COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.|pdf=|usr=008}}
+{{tp|p=32529516|t=2020. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2.|pdf=|usr=008}}
+{{tp|p=32447630|t=2020. COVID-19 and the nervous system.|pdf=|usr=008}}
-{{tp|p=32377594|t=2020. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2 |pdf=|usr=}}
+{{tp|p=32423471|t=2020. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients.|pdf=|usr=008}}
-{{tp|p=32389704|t=ä. Pain: A potential new label of COVID-19 |pdf=|usr=}}
-{{tp|p=32387342|t=ä. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A  neurovascular complication of COVID-19 |pdf=|usr=}}
-{{tp|p=32409210|t=ä. Coexistence of COVID-19 and acute ischemic stroke report of four cases |pdf=|usr=}}
-{{tp|p=32355557|t=ä. Ophthalmic manifestations of novel coronaviruses: precautionary measures and diagnostic possibilities |pdf=|usr=}}
-{{ttp|p=32388138|t=2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection |pdf=|usr=}}
-{{tp|p=32380269|t=2020. The COVID-19 Pandemic: Consideration for Brain Infection |pdf=|usr=}}
-{{tp|p=32342265|t=ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome |pdf=|usr=}}